Juergen Wolf

Second-line nivolumab in relapsed small-cell lung cancer: CheckMate 331☆

David R. Spigel, David Vicente, Tudor–Eliade Ciuleanu et al. · Annals of Oncology · 2021 · 263 citations · Full text

BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: interim report from a trial of the German Hodgkin's Lymphoma Study Group.

Volker Diehl, Jeremy Franklin, Dirk Hasenclever et al. · Journal of Clinical Oncology · 1998 · 194 citations

Peripheral blood mononuclear cells of a patient with advanced Hodgkin's lymphoma give rise to permanently growing Hodgkin-Reed Sternberg cells

Juergen Wolf, Ursula Kapp, Heribert Bohlen et al. · Blood · 1996 · 185 citations · Full text

ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer

Antonio Passaro, Natasha B. Leighl, Fiona Blackhall et al. · Annals of Oncology · 2022 · 181 citations · Full text

Medicine, Pathology, Cancer Treatment +6

Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC

Marcelo V. Negrão, Haniel A. Araújo, Giuseppe Lamberti et al. · Cancer Discovery · 2023 · 166 citations · Full text